As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Quantum X Labs Inc. The largest reported stake is L.I.A. Pure Capital Ltd.'s, at 9.99%. 9 filings are on record since August 12, 2025 (Schedule 13G/A, August 19, 2026).
Sell to companies like Quantum X Labs Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Nissim Daniel · Sole voting: 394,554 · Shared voting: 1,744,554 · Sole dispositive: 394,554 · Shared dispositive: 1,744,554 · SCHEDULE 13G/A, 2026-08-20
- · Reporting person: L.I.A. Pure Capital Ltd. · Sole voting: 2,179,600 · Shared voting: 2,179,600 · Sole dispositive: 2,179,600 · Shared dispositive: 2,179,600 · SCHEDULE 13G/A, 2026-08-19
- · Reporting person: Capitalink Ltd. · Sole voting: 667,034 · Shared voting: 0 · Sole dispositive: 667,034 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-05-15
- · Holder: Nissim Daniel · Percent: 8.65% · SCHEDULE 13G/A
- · Holder: L.I.A. Pure Capital Ltd. · Percent: 9.99% · SCHEDULE 13G/A
Quantum X Labs Inc. has 9 Schedule 13D or 13G filings on record since 2025-08-12. 2 holders' latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| L.I.A. Pure Capital Ltd. | 9.99% | 2,179,600 | SCHEDULE 13G/A, 2026-08-19 | 2026-06-30 |
| 7.61% | 1,744,554 | SCHEDULE 13G/A, 2026-08-20 | 2026-06-30 | |
| Capitalink Ltd. | 4.99% | 667,034 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| MMCAP International Inc. SPC | 1.75% | 115,995 | SCHEDULE 13G/A, 2025-08-12 | 2025-06-30 |
Holding shares or following this stake? See who's behind Quantum X Labs Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Quantum X Labs Inc. and the records around it.
Quantum X Labs Inc. elsewhere on the record
- Leadership changes Sep 2026
- Form D filing Jul 2025
- Who owns it
Companies that share a holder
- Capitalink Ltd. also filed stake reports on 3 other companies: Clearmind Medicine Inc. (May 2026)
- Nissim Daniel also filed stake reports on 5 other companies: Clearmind Medicine Inc (Mar 2026)
- L.I.A. Pure Capital Ltd. also filed stake reports on 10 other companies: Evogene Ltd. (Oct 2026), Clearmind Medicine Inc. (May 2026), Maris-Tech Ltd. (May 2026)
Watch Quantum X Labs Inc.
Get an email when Quantum X Labs Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Quantum X Labs Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Quantum X Labs Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Quantum X Labs Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| L.I.A. Pure Capital Ltd. | 2,179,600 | 2,179,600 | 2,179,600 | 2,179,600 | SCHEDULE 13G/A, 2026-08-19 |
| Xylo Technologies Ltd. | 315,066 | 0 | 315,066 | 0 | SCHEDULE 13G/A, 2026-08-19 |
| Nissim Daniel | 394,554 | 1,744,554 | 394,554 | 1,744,554 | SCHEDULE 13G/A, 2026-08-20 |
| J.B.D Innovation Ltd. | 0 | 1,350,000 | 0 | 1,350,000 | SCHEDULE 13G/A, 2026-08-20 |
| Capitalink Ltd. | 667,034 | 0 | 667,034 | 0 | SCHEDULE 13G/A, 2026-05-15 |
The latest filing identifies Quantum X Labs Inc. by CUSIP 926711300 and gives its principal executive office as Atrium Tower, 2 Jabotinsky Street, Ramat Gan (SCHEDULE 13G/A, 2026-08-20).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-12 | MMCAP International Inc. SPC | 1.75% | SCHEDULE 13G/A |
| 2025-09-11 | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G |
| 2025-10-22 | Nissim Daniel | 5.72% | SCHEDULE 13G |
| 2026-03-12 | Capitalink Ltd. | 5.04% | SCHEDULE 13G |
| 2026-05-15 | Nissim Daniel | 8.65% | SCHEDULE 13G/A |
| 2026-05-15 | Capitalink Ltd. | 4.99% | SCHEDULE 13G/A |
| 2026-05-15 | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G/A |
| 2026-08-19 | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G/A |
| 2026-08-20 | Nissim Daniel | 7.61% | SCHEDULE 13G/A |
Questions about who owns Quantum X Labs Inc.
Who owns Quantum X Labs Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Quantum X Labs Inc.: L.I.A. Pure Capital Ltd. (9.99%, Schedule 13G/A, filed 2026-08-19) and Nissim Daniel (7.61%, Schedule 13G/A, filed 2026-08-20).
Who are the largest shareholders of Quantum X Labs Inc.?
By the share each holder's latest filing reports, the largest holders of Quantum X Labs Inc. on this page are L.I.A. Pure Capital Ltd. (9.99%) and Nissim Daniel (7.61%).
When did L.I.A. Pure Capital Ltd. buy into Quantum X Labs Inc.?
The filings give report dates, not purchase dates. The earliest filing from L.I.A. Pure Capital Ltd. on this page is the Schedule 13G, filed 2025-09-11, reporting 9.99%; its latest, Schedule 13G/A filed 2026-08-19, reports 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Quantum X Labs Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 22, 2026 | Leadership change: Amihay Hadad departs, Chief Executive Officer | — | Leadership changes | Source |
| May 15, 2026 | Leadership change: Yakov Baranes appointed, Chief Executive Officer | — | Leadership changes | Source |
| July 24, 2025 | Form D, private offering | $8.90M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for Quantum X Labs Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.